Detection of HER-2 gene amplification using chromogenic in situ hybridization (CISH) and tissue microarray: Correlation with HER2 protein expression using immunohistochemistry

被引：0
|
作者：
Askeland, RW [1 ]
Vasef, MA [1 ]
机构：
[1] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
来源：
MODERN PATHOLOGY | 2003年 / 16卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1457
引用
收藏
页码：318A / 319A
页数：2
相关论文
共 50 条
  • [21] Prognostic value of HER-2 gene amplification detected by chromogenic in situ hybridization (CISH) in metastatic breast cancer
    Todorovic-Rakovic, Natasa
    Jovanovic, Danica
    Neskovic-Konstantinovic, Zora
    Nikolic-Vukosavljevic, Dragica
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2007, 82 (03) : 262 - 268
  • [22] Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer
    Furrer, Daniela
    Jacob, Simon
    Caron, Chantal
    Sanschagrin, Francois
    Provencher, Louise
    Diorio, Caroline
    ANTICANCER RESEARCH, 2017, 37 (06) : 3323 - 3329
  • [23] Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer
    Yano, T
    Doi, T
    Ohtsu, A
    Boku, N
    Hashizume, K
    Nakanishi, M
    Ochiai, A
    ONCOLOGY REPORTS, 2006, 15 (01) : 65 - 71
  • [24] Automatic quantification of HER2 amplification in invasive breast cancer using chromogenic in situ hybridization (CISH) and computational pathology
    Hossain, M. S.
    Nakamura, T.
    Hanna, M.
    Uraoka, N.
    Ross, D. S.
    Hameed, R.
    Yamaguchi, M.
    Yagi, Y.
    VIRCHOWS ARCHIV, 2019, 475 : S18 - S18
  • [25] Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH)
    Kato, Nobuaki
    Itoh, Hitoshi
    Serizawa, Akihiko
    Hatanaka, Yutaka
    Umemura, Shinobu
    Osamura, R. Yoshiyuki
    PATHOLOGY INTERNATIONAL, 2010, 60 (07) : 510 - 515
  • [26] Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
    Jiang, Huiyong
    Bai, Xiaoyan
    Zhang, Cheng
    Zhang, Xuefeng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05) : 5519 - 5527
  • [27] Use of chromogenic in-situ hybridization (CISH) in determining Her2 status
    Jundi, M
    Selim, S
    Phillips, S
    Garcia, FU
    LABORATORY INVESTIGATION, 2003, 83 (01) : 35A - 35A
  • [28] IMMUNHISTOCHEMICAL EXPRESSION OF HER-2 IN BLADDER CANCER DOES NOT ALWAYS MATCH WITH HER2 GENE AMPLIFICATION BY IN SITU HYBRIDIZATION
    Franceschini, Tania
    Giunchi, Francesca
    Capizzi, Elisa
    Zagnoni, Stefano
    Fiorentino, Michelangelo
    ANTICANCER RESEARCH, 2019, 39 (03) : 1619 - 1620
  • [29] Correlation of In Situ HER2 RNA Expression With HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Categories in Breast Cancer
    Tseng, Yu-Fen
    Li, Yu-Chia
    Lee, Yi-Hsuan
    Hu, Hsiang-We
    Zhang, Man-San
    Hung, Tze-Chun
    Lien, Huang-Chun
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (03) : e48 - e56
  • [30] Role of chromogenic in situ hybridization (CISH™) in the evaluation of HER2 status in breast carcinoma:: Comparison with immunohistochemistry and FISH
    Li-Ning-T, E
    Ronchetti, R
    Torres-Cabala, C
    Merino, MJ
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2005, 13 (04) : 343 - 351
12345